Previous 10 | Next 10 |
LOWELL, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
Rapid Micro Biosystems, Inc. (RPID) Q3 2022 Earnings Conference Call November 10, 2022 08:30 ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participant...
Rapid Micro Biosystems press release ( NASDAQ: RPID ): Q3 GAAP EPS of -$0.38 misses by $0.01 . Revenue of $4.74M (-31.3% Y/Y) beats by $0.77M . The Company is reaffirming its prior full year 2022 revenue outlook of at least $17.0 million vs consensus of $16.99M...
Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million LOWELL, Mass., Nov. 10, 2022 (GLOBE NEWSW...
LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of heal...
Rapid Micro Biosystems ( NASDAQ: RPID ) said it will introduce a new software, RMBNucleus Mold Alarm to rapidly detect environmental molds in the pharmaceutical manufacturing process. RMBNucleus is expected to be available on the Growth Direct System before the end of ...
LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of heal...
LOWELL, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of heal...
LOWELL, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of hea...
Rapid Micro Biosystems, Inc. (RPID) Q2 2022 Earnings Conference Call August 12, 2022 08:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations & Corporate Communications Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief...
News, Short Squeeze, Breakout and More Instantly...
Rapid Micro Biosystems Inc. Company Name:
RPID Stock Symbol:
NASDAQ Market:
Rapid Micro Biosystems Inc. Website:
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...